AI & Data, SaaS

Inato

Matches the right sites to the right clinical research study, globally

2016 – France 🇫🇷 & US (NYC) 🇺🇸

Inato matches clinical trials with qualified sites worldwide and optimizes site performance throughout the trial.

It helps biopharma companies and CROs identify high-performing sites, increase the pool of available patients, and deliver efficient, on-time studies.

The platform is built with doctors, for doctors—to tackle the most complex research challenges.

Back to portfolio
Inato team
Founders
Kourosh Davarpanah
William Pambrun
Jean-David Zeitoun
Philippe Ravaudinato
AI Data SaaS

Partners involved

What we say

Marie Brayer

Marie Brayer

Thanks to Inato’s AI technology, big pharma and biotech companies can significantly reduce development costs for new drugs, notably by identifying the best hospitals for any given trial. We were really impressed to see how, with very limited time and resources, the team has already provided an impressive proof of concept with one of the world’s leading names in healthcare, and shown their ability to execute.